Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal cell of prostate epithelium | 4 studies | 43% ± 8% |
Insufficient scRNA-seq data for expression of KLK4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 19100.16 | 244 / 245 | 100% | 1538.63 | 502 / 502 |
thymus | 99% | 243.54 | 644 / 653 | 23% | 4.97 | 138 / 605 |
breast | 59% | 118.86 | 273 / 459 | 62% | 6.19 | 688 / 1118 |
adrenal gland | 76% | 146.53 | 197 / 258 | 34% | 21.38 | 79 / 230 |
intestine | 57% | 50.30 | 548 / 966 | 14% | 0.92 | 75 / 527 |
uterus | 48% | 194.05 | 81 / 170 | 12% | 2.71 | 55 / 459 |
skin | 45% | 18.97 | 814 / 1809 | 10% | 1.08 | 45 / 472 |
kidney | 24% | 9.99 | 21 / 89 | 16% | 21.55 | 142 / 901 |
bladder | 14% | 8.38 | 3 / 21 | 12% | 1.25 | 62 / 504 |
lung | 19% | 6.83 | 108 / 578 | 6% | 0.52 | 67 / 1155 |
pancreas | 1% | 0.55 | 4 / 328 | 19% | 0.80 | 34 / 178 |
esophagus | 7% | 2.86 | 94 / 1445 | 11% | 0.60 | 21 / 183 |
brain | 16% | 4.09 | 422 / 2642 | 1% | 0.03 | 8 / 705 |
adipose | 16% | 7.93 | 197 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 15% | 10.99 | 141 / 929 | 0% | 0 | 0 / 0 |
stomach | 1% | 0.15 | 3 / 359 | 12% | 2.28 | 34 / 286 |
ovary | 7% | 4.20 | 12 / 180 | 4% | 0.20 | 19 / 430 |
spleen | 10% | 2.20 | 25 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0.16 | 1 / 226 | 7% | 2.50 | 30 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.32 | 2 / 29 |
blood vessel | 5% | 7.22 | 64 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.12 | 2 / 45 |
muscle | 2% | 0.72 | 16 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.41 | 7 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0031214 | Biological process | biomineral tissue development |
GO_0006508 | Biological process | proteolysis |
GO_0097186 | Biological process | amelogenesis |
GO_0030141 | Cellular component | secretory granule |
GO_0005576 | Cellular component | extracellular region |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KLK4 |
Protein name | Kallikrein-4 (EC 3.4.21.-) (Enamel matrix serine proteinase 1) (Kallikrein-like protein 1) (KLK-L1) (Prostase) (Serine protease 17) KLK4-KLKP1 fusion protein Kallikrein Kallikrein 4 splice variant Kallikrein related peptidase 4 Kallikrein-related peptidase 4 Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a (Kallikrein B1) (Kallikrein related peptidase 4) Kallikrein 4 (EC 3.4.21.-) (Kallikrein related peptidase 4) KLK4 protein |
Synonyms | KLNB1 hCG_1641510 PRSS17 PSTS EMSP1 fusion KLKP1 |
Description | FUNCTION: Has a major role in enamel formation . Required during the maturation stage of tooth development for clearance of enamel proteins and normal structural patterning of the crystalline matrix (By similarity). . |
Accessions | ENST00000324041.6 ENST00000593885.1 ENST00000598305.5 Q9Y5K2 Q4VB17 Q4VB18 ENST00000431178.2 [Q9Y5K2-2] ENST00000602148.1 M0QYN5 Q96PT1 Q96PT0 Q5BQA0 A0A5B8NGJ8 B1GRN1 A0A0C4DFQ5 |